The Efficacy of Methylphenidate Use in Children Diagnosed With Attention Deficit Hyperactivity Disorder With
Saliha Baykal1, Abdullah Bozkurt2
1Department of Child and Adolescent Psychiatry, Tekirdağ Namik Kemal University Faculty of Medicine, Tekirdağ.
Purpose:
This study explored the effect of methylphenidate therapy on the emotional impulsivity profile of medication-naive children diagnosed with attention deficit hyperactivity disorder (ADHD) with emotional dysregulation-emotional impulsivity subtype.
Methods:
The emotional dysregulation scores of 34 patients diagnosed with ADHD, aged 6 to 12 years, with no comorbidity or medication use, and who met the subgroup criteria defined as an emotional dysregulation-emotional impulsivity profile using CBCL (4 to 18) were compared before and after methylphenidate therapy.
Findings:
Methylphenidate resulted in a statistically significant decrease in emotional impulsivity, one of the emotional dysregulation subtypes, in children with ADHD with an emotional impulsivity profile and no comorbid psychiatric disease. ADHD subtype, disease severity, and additional medication use did not affect the change in emotional impulsivity scores.
Implications:
The study findings show that methylphenidate was effective against the symptoms of the emotional impulsivity emotional dysregulation subtype in the ADHD group without comorbidities, with no need for additional medication. However, our findings need to be supported by large-sample observational studies, and the response to methylphenidate needs to be compared among different emotional dysregulation subtypes.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Oppositional Defiant Disorder
Diagnostic Criteria and...
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
